Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy

Although there have been advances in the prevention and diagnosis of hepatocellular carcinoma (HCC) in recent years, many HCC patients are still diagnosed with advanced stage. Systemic therapy is indicated for unresectable HCC (uHCC) with major vascular invasion and/or extrahepatic metastases, and t...

Full description

Bibliographic Details
Main Authors: Kyoko Oura, Asahiro Morishita, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Joji Tani, Masafumi Ono, Chikara Ogawa, Akio Moriya, Tomonori Senoo, Akemi Tsutsui, Takuya Nagano, Koichi Takaguchi, Takashi Himoto, Tsutomu Masaki
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
hepatocellular carcinoma
sarcopenia
atezolizumab
bevacizumab
immunotherapy
grip strength
Online Access:https://www.mdpi.com/2072-6694/15/12/3243

Internet

https://www.mdpi.com/2072-6694/15/12/3243

Similar Items